Several leaders in the field, including vascular neurologists and interventional neuroradiologists, say the Centers for Medicare and Medicaid Services' decision lacks supporting evidence and is premature.
Neuro-oncologists discuss the gaps in access to equitable care and the ways they hope the investment into research will benefit their patients.
The technique, also known as optical EMG, let researchers distinguish in vivo the molecular fingerprint of diseased muscle in a mouse model of amyotrophic lateral sclerosis.
See More Videos
